Skip to main content

Table 4 Characteristics among patients with Antiphospholipid Syndrome

From: The trends in the incidence and thrombosis-related comorbidities of antiphospholipid syndrome: a 14-year nationwide population-based study

Characteristics Antiphospholipid Syndrome p-value
No (n = 76,652) Yes (n = 19,163)
n % n %
Age, years      0.49
 < 40 36,441 47.54 9027 47.11  
 40–60 16,662 21.74 4171 21.77  
 > 60 23,549 30.72 5965 31.13  
mean ± SD 42.71 ± 26.21   43.02 ± 26.45   0.15
Gender      0.82
 Female 45,015 58.73 11,237 58.64  
 Male 31,637 41.27 7926 41.36  
Comorbidity
 Diabetes mellitus 323 0.42 3548 18.51 <.0001
 Hypertension 308 0.40 3632 18.95 <.0001
 Hyperlipidemia 267 0.35 2729 14.24 <.0001
 Stroke 285 0.37 4006 20.90 <.0001
 Heart failure 302 0.39 2646 13.81 <.0001
 Atrial fibrillation 313 0.41 411 2.14 <.0001
 Myocardial infarction 284 0.37 2197 11.46 <.0001
 PAOD 256 0.33 1879 9.81 <.0001
 Chronic kidney disease 324 0.42 3072 16.03 <.0001
 COPD 348 0.45 3672 19.16 <.0001
 Deep vein thrombosis 238 0.31 1167 6.09 <.0001
 Pulmonary embolism 284 0.37 410 2.14 <.0001
 Systemic lupus erythematosus 319 0.42 419 2.19 <.0001
 Rheumatoid arthritis 305 0.40 816 4.26 <.0001
 Systemic sclerosis 284 0.37 53 0.28 0.03
 Sjogren’s syndrome 26 0.03 498 2.6 <.0001
 Polymyositis & dermatomyositis 9 0.01 34 0.18 <.0001
  1. Data shown as n(%) or mean ± SD
  2. Using 1:4 frequency matching